English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduGrowth hormone improves liver health in patients with nonalcoholic fatty liver disease (NAFLD) by reducing liver fat and inflammation, according to a new study presented Tuesday, June 14 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Tag: ENDO 2022
Study finds disparities in access to insulin pumps among youth with type 1 diabetes
Over the past 20 years, despite the overall increase in the use of insulin pumps, there have been few improvements in the ethnic, racial and socioeconomic inequities in insulin pump use among youth with type 1 diabetes, according to a new study presented Tuesday, June 14 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Researchers develop pancreatic beta-cell restoring therapy for treating type 1 diabetes
Researchers have successfully treated type 1 diabetes in mice using pancreatic beta-cell, target-specific, chimeric antigen-receptor (CAR) regulatory T cells (Tregs), and demonstrated the feasibility of their approach to treat the human condition according to data being presented Monday, June 13 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Mouse model of transgender men finds active testosterone worsens IVF outcomes
Active testosterone therapy for transgender men may negatively impact IVF outcomes, suggests a mouse study being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Study finds long-term 10% weight loss with anti-obesity medications and lifestyle changes
A new study finds overweight and obese people maintained an average weight loss of 10.6% over 3 to 5 years with a program of lifestyle changes in combination with anti-obesity medications. Weight loss of more than 10% provides significant health benefits, according to researchers who are presenting their findings Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
People who consume too much high fructose corn syrup could be at risk for NAFLD
High fructose consumption should be avoided to prevent the development of non-alcoholic fatty liver disease (NAFLD), according to research being presented Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Longer treatment with puberty-delaying medication in transgender youth leads to lower bone mineral density
A longer duration of treatment with puberty-delaying medications among transgender youth is associated with lower bone mineral density, according to a new study that will be presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
COVID-19 pandemic stress impacts ovulation
Life disruptions and the stresses of the COVID-19 pandemic led to disturbed ovulation with decreased progesterone durations or levels, according to research being presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Endocrine-disrupting chemical exposure in womb impact fear, anxiety behavior in rats
Prenatal exposure to endocrine-disrupting chemicals found in everyday products may interfere with the developing offspring’s brain, according to a rat study being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Adult growth hormone deficiency increases medical costs, risk of additional health conditions
Growth hormone deficiency (GHD) among adults is associated with greater medical costs and an increased rate of other health conditions compared with those without GHD, according to industry-sponsored research being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
AI can be used to identify benign thyroid nodules and reduce unnecessary biopsies
Artificial intelligence (AI) can be used to identify thyroid nodules seen on thyroid ultrasound that are very unlikely to be cancerous, reducing a large number of unnecessary biopsies, according to a new study being presented Saturday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Testosterone improves quality of life, sexual function, and delayed verbal recall in men with uncontrolled type 2 diabetes
Testosterone replacement therapy improved sexual symptoms, libido, symptom severity, delayed verbal recall and overall quality of life among people with poorly controlled type 2 diabetes and hypogonadism, according to research being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Bias may play a role in underdiagnoses of prediabetes
The accurate diagnosis of prediabetes in the primary care setting might depend on a patient’s age, BMI, gender, race and certain comorbidities, according to research being presented at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Male contraceptive pills show promise in new study
Two experimental male contraceptive pills appear to effectively lower testosterone without causing unacceptable side effects, according to a new study that will be presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Drinking coffee does not hinder the absorption of liquid thyroid medication
A new study conducted by Vertice Pharma confirms the absorption of an oral levothyroxine sodium solution (Thyquidity® 100g/ 5mL) was not affected by consuming coffee 5 minutes after the dose, according to research being presented Saturday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Probiotic bacteria may enhance tamoxifen effectiveness in treatment of ER+ breast cancer
Probiotic bacteria may enhance anti-cancer activities of the breast cancer drug tamoxifen and other endocrine-targeted therapies, which could help reduce the risk of estrogen receptive positive (ER+) breast cancer, suggests a new study presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Teens ate less ultra-processed food consumption during pandemic, reversing trend of three decades
For the first time in the last 30 years, the consumption of ultra-processed foods among teenagers in the United States declined during the COVID-19 pandemic, according to a new study presented at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
COVID-19 vaccination appears to be safe for patients treated for hypothyroidism
Inactivated and mRNA COVID-19 vaccines appear to be safe for patients treated for hypothyroidism,
according to a new study being presented at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga. The study found these vaccines do not cause significant fluctuations in thyroid function and are not associated with increased risks of emergency department visits or unscheduled hospitalizations.
Maintaining normal weight early in life may help prevent male infertility
New research suggests that more careful control of body weight in childhood and adolescence could help prevent male infertility later in life. The researchers will present their findings on Saturday, June 11 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Moderation may disrupt addictive nature of wireless mobile devices and adverse health outcomes
Encouraging moderation, balance and real-life engagement coupled with education may combat the overuse of wireless mobile devices and subsequent adverse health outcomes, according to research being presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Addressing stress and postpartum symptoms early may reduce risk for type 2 diabetes in women with gestational diabetes
Addressing stress early on in postpartum women who recently experienced gestational diabetes might help curb an increased risk for type 2 diabetes, according to research being presented Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
East Coast is home to greatest hot spots for diabetes complications
The East Coast of the United States, especially Florida, and Texas have some of the greatest hot spots for long-term diabetes complications, according to research being presented Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Study links diabetes and worse outcomes in long-term survivors of metastatic breast cancer
Women who are longer-term survivors of metastatic breast cancer may have a worse survival rate if they have diabetes and poorly controlled blood sugar levels, according to a new study presented Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Empagliflozin may decrease risk of kidney stones in people with diabetes
The diabetes drug empagliflozin may decrease the risk of kidney stones in patients with type 2 diabetes, according to a new study presented Sunday, June 12 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Male runners who are energy deficient may be at higher risk for fractures
Male runners who do not receive enough energy from their diet may be at risk for stress fractures, according to a new study presented Saturday, June 11 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Cost of mental health disorders linked with polycystic ovary syndrome almost $6 billion in 2021
The cost of mental health disorders associated with polycystic ovary syndrome (PCOS) – depression, anxiety and eating disorders – reached almost $6 billion in 2021, according to a new study presented Monday, June 13 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Chemicals in personal care products cause harmful effects in breast cancer cells from Black women
Chemicals called parabens, which are found in widely used hair and personal care products, cause harmful effects in breast cancer cells from Black women, according to a new study being presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Unhealthy diet helps explain association between food insecurity and obesity
There is a greater prevalence of obesity and higher body fat among people who face food insecurity, according to research being presented Sunday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Study finds strong association between prediabetes and heart attack risk
Prediabetes appears to be a strong independent risk factor for heart attacks, according to a new study presented Saturday, June 11 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Increased fracture risk in patients using insulin compared to metformin
Patients with type 2 diabetes have an increased risk for fractures, despite their normal-to-high bone mineral density, according to research being presented Saturday, June 11 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Stem-cell based therapy shows promise in treating high-risk type 1 diabetes
An investigative stem cell-based therapy called PEC-Direct, designed to act as a replacement pancreas, has the potential to provide blood sugar control in patients with high-risk type 1 diabetes, suggests a clinical study presented Saturday, June 11 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Phase 3 study finds fezolinetant reduces the frequency and severity of menopausal hot flashes
Fezolinetant significantly reduced the frequency and severity of moderate-to-severe vasomotor symptoms (VMS), or hot flashes, associated with menopause, according to a Phase 3 industry-sponsored study being presented Saturday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Suppressed ovarian follicle development in women with obesity may explain reduced fertility
Women with obesity, even those with regular menstrual cycles, have suppressed ovarian follicle development and reduced production of reproductive hormones, which may underlie reduced fertility, according to a new study being presented Saturday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
Analysis finds little evidence of heart problems in men undergoing testosterone treatment
Previous clinical trials have provided insufficient evidence to decide whether testosterone causes heart problems in men during the first year of treatment, according to research being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga., and published in The Lancet Healthy Longevity.